First human test for new eczema treatment begins
NCT ID NCT06920693
Summary
This is the very first study in humans for a new potential eczema (atopic dermatitis) treatment called GB-7624. It will test the safety and side effects of single and multiple doses in 40 healthy adult volunteers. The main goal is to see how the body handles the drug and what dose levels are safe before testing it in people with eczema.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Generate Biomedicines Clinical Site
Herston, Queensland, 4007, Australia
Conditions
Explore the condition pages connected to this study.